Analyst Price Target is $26.38
▲ +70.05% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for DarioHealth in the last 3 months. The average price target is $26.38, with a high forecast of $35.00 and a low forecast of $15.25. The average price target represents a 70.05% upside from the last price of $15.51.
Current Consensus is
The current consensus among 6 contributing investment analysts is to buy stock in DarioHealth. This Buy consensus rating has held steady for over two years.
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario Tools, which are devices that integrate with applications on a user's smartphone; DarioEngage, a population health management platform; and the Dario Loop, an AI-driven journey engine. It also sells device-specific disposables test strip cartridges, lancets, and Dario Blood Glucose Monitoring System; and Dario Smart Diabetes Management Solution, which includes tools to help diabetic patients manage their disease. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is based in New York, New York.